‘ Three Stocks That Could Help Make You a Millionaire Over Time\n\nThe gene editing company, CRISPR Therapeutics (NASDAQ:CRSP), announced the resignation of one of its board members, but assured that it was not due to any disagreement with the company. This news comes as the company has just started its growth story as a commercial-stage company. CRISPR Therapeutics has seen significant advancements this year, with its gene-editing technology being authorized for use in the UK and receiving approval in the US for its treatment of sickle cell disease and beta thalassemia. With blockbuster potential and a growing pipeline, CRISPR Therapeutics is poised for long-term success.\n\nTeladoc Health (NYSE:TDOC) is another stock that stands out as a potential millionaire-maker. Facing concerns about its lack of profitability, the company has taken steps towards balancing its quest for revenue growth with the goal of achieving profitability. With a focus on chronic care, a key market with high demand, Teladoc is well-positioned for long-term success.\n\nJohnson & Johnson (NYSE:JNJ) is a company that offers investors both stability and potential for growth. As a Dividend King, the company has a track record of consistently increasing its dividend for over 50 consecutive years. With a strong track record of rewarding shareholders and a solid business foundation, Johnson & Johnson is a stock that could help make you a millionaire over time.\n\nIn a CRISPR Therapeutics, Teladoc Health, and Johnson & Johnson are three stocks that, together and as part of a diversified portfolio, could help make you a millionaire over the long haul.’
‘ Three Stocks That Could Help Make You a Millionaire Over Time\n\nThe gene editing company, CRISPR Therapeutics (NASDAQ:CRSP), announced the resignation of one of its board members, but assured that it was not due to any disagreement with the company. This news comes as the company has just started its growth story as a commercial-stage company. CRISPR Therapeutics has seen significant advancements this year, with its gene-editing technology being authorized for use in the UK and receiving approval in the US for its treatment of sickle cell disease and beta thalassemia. With blockbuster potential and a growing pipeline, CRISPR Therapeutics is poised for long-term success.\n\nTeladoc Health (NYSE:TDOC) is another stock that stands out as a potential millionaire-maker. Facing concerns about its lack of profitability, the company has taken steps towards balancing its quest for revenue growth with the goal of achieving profitability. With a focus on chronic care, a key market with high demand, Teladoc is well-positioned for long-term success.\n\nJohnson & Johnson (NYSE:JNJ) is a company that offers investors both stability and potential for growth. As a Dividend King, the company has a track record of consistently increasing its dividend for over 50 consecutive years. With a strong track record of rewarding shareholders and a solid business foundation, Johnson & Johnson is a stock that could help make you a millionaire over time.\n\nIn a CRISPR Therapeutics, Teladoc Health, and Johnson & Johnson are three stocks that, together and as part of a diversified portfolio, could help make you a millionaire over the long haul.’$CRSP2023-12-21T10:33:46.228Z